rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Hans Edgar Bishop

Director

Company insider

Files Form 4 as: Director, Sana Biotechnology; Director, Lyell Immunopharma; Director, Agilent Technologies; Director, Celgene Corp /de/; CEO & President, Juno Therapeutics; Director, Avanir Pharmaceuticals; Chief Operating Officer, Dendreon.

Every Form 4 they filed

In numbers

Trades disclosed
147
Buys
0
Sells
11
Bought
$0
Sold
$34.5M
Companies
7
Companies where not an officer
5
First trade
29 Jan 2010
Last trade
5 Oct 2026
Last filed
6 Oct 2026

Companies traded

Where they are an officer
Juno TherapeuticsDirector, Officer · last 5 Mar 20180 buys · 11 sells
DendreonOfficer · last 29 Jul 20110 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SANA Sana BiotechnologyDirector · Biotechnology · last 5 Oct 20260 buys · 0 sells
LYEL Lyell ImmunopharmaDirector · Biotechnology · last 14 Jun 20240 buys · 0 sells
A Agilent TechnologiesDirector · Life-science tools · last 15 Mar 20240 buys · 0 sells
Celgene Corp /de/Director · last 20 Nov 20190 buys · 0 sells
Avanir PharmaceuticalsDirector · last 12 Feb 20140 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Oct 2026filed 6 Oct 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—8,680 at $0.00filing
6 Jul 2026filed 7 Jul 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—6,297 at $0.00filing
6 Jul 2026filed 7 Jul 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—6,297 at $0.00filing
4 Jun 2026filed 5 Jun 2026SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
4 Jun 2026filed 5 Jun 2026SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—90,000 at $0.00filing
6 Apr 2026filed 8 Apr 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—7,763 at $0.00filing
6 Apr 2026filed 8 Apr 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—7,763 at $0.00filing
5 Jan 2026filed 6 Jan 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—6,157 at $0.00filing
5 Jan 2026filed 6 Jan 2026SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—6,157 at $0.00filing
6 Oct 2025filed 7 Oct 2025SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—5,628 at $0.00filing
7 Jul 2025filed 8 Jul 2025SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—7,842 at $0.00filing
5 Jun 2025filed 9 Jun 2025SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
7 Apr 2025filed 8 Apr 2025SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—16,339 at $0.00filing
6 Jan 2025filed 7 Jan 2025SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—14,285 at $0.00filing
7 Oct 2024filed 9 Oct 2024SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—5,938 at $0.00filing
5 Jul 2024filed 8 Jul 2024SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—4,911 at $0.00filing
14 Jun 2024filed 17 Jun 2024LYEL Lyell Immunopharmaoption or derivative · BiotechnologySEC FORM 4 Code A—130,000 at $0.00filing
6 Jun 2024filed 15 Jul 2024SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
6 Jun 2024filed 7 Jun 2024SANA Sana Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—54,278 at $0.00filing
5 Apr 2024filed 8 Apr 2024SANA Sana BiotechnologyBiotechnologySEC FORM 4 Code A—2,774 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed11

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.